-
- Target Alle EGR4 Produkte
- EGR4 (Early Growth Response 4 (EGR4))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Immunogen (Imm)
- Sequenz
- NCGSQGDYQA APE
- Produktmerkmale
- The peptide was used in the production of ABIN370252 - Goat Anti-EGR4 Antibody. It is currently untested in blocking applications.
-
-
- Applikationshinweise
- When peptides are reconstituted in 200ul water, the concentration would be also 0.5mg/ml. To start, the best ratio would be 1:1 (which means molar excess of peptides relative to antibodies when identical volumes are mixed). Please mix equal volumes of peptide and antibody at the required dilution and leave at ambient temperature. Best is to have two identical blots, to be incubated with equal amount of antibodies, but one with the antibodies pre-adsorbed to the peptide for 20min. Then incubate and develop in parallel the two blots.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
- Buffer
- 100µg of Lyophilised peptide, formulation De-ionized (DI) water.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Shipped at ambient temperature, store at -20°C.
-
- Target
- EGR4 (Early Growth Response 4 (EGR4))
- Synonyme
- EGR4 Peptide, NGFI-C Peptide, NGFIC Peptide, PAT133 Peptide, NGF1-C Peptide, pAT133 Peptide, Egr4l1 Peptide, early growth response 4 Peptide, EGR4 Peptide, Egr4 Peptide
-
Sie sind hier:
